Glycomet (Metformin) Tablets

Glycomet is the brand name for oral metformin tablets, a biguanide medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes. We carry Glycomet as immediate-release tablets in two strengths, giving customers a straightforward way to match the listing to a prescribed dose.

Product Summary

Glycomet tablets contain metformin hydrochloride as the sole active ingredient and belong to the biguanide class of antidiabetic medicines. Metformin lowers blood glucose mainly by reducing liver glucose production and improving how the body's tissues respond to insulin, rather than by stimulating insulin release. Because of this mechanism, it does not typically cause low blood sugar on its own, which sets it apart from sulfonylureas such as glipizide or glimepiride.

Essential Facts

Metformin is usually taken with meals to reduce stomach upset, and treatment commonly starts at a low dose that is increased gradually over one to two weeks as the body adjusts. Many regimens begin around 500 mg once or twice daily with food, with the total daily dose titrated upward under medical guidance based on blood sugar response and tolerance. Full glucose-lowering benefit typically develops over days to a few weeks rather than immediately after the first dose.

Routine care with metformin includes periodic checks of kidney function and blood glucose, since reduced kidney function can allow the drug to build up and raise the risk of a rare but serious complication called lactic acidosis. People who drink alcohol heavily, have significant liver disease, or experience conditions that affect breathing or circulation should discuss these factors with a prescriber before starting therapy.

Available Options

We offer Glycomet tablets in 250 mg and 500 mg strengths, with package sizes chosen to fit both short-term trials and longer, ongoing supply.

Choosing a package size mainly depends on the prescribed daily dose and how far ahead a customer wants to plan a refill; our support team can help confirm which combination lines up with a given prescription.

Important Notes

Glycomet tablets are classified as a prescription medicine in the United States and should be used under a prescriber's direction. Metformin itself is authorized for human use in the US and has an established safety record. US labeling notes that human data during pregnancy are limited, while national diabetes guidance identifies insulin as the preferred treatment in that setting; whether to start, continue, or switch therapy is an individualized prescriber decision. Breastfeeding is generally not recommended during metformin treatment because the drug passes into human milk and effects on a nursing infant have not been fully established. In children, immediate-release metformin tablets have an established role starting at age 10, with age-specific dosing and gradual titration.

Common side effects include nausea, diarrhea, and a metallic taste, which often ease once the dose has been titrated slowly. Store Glycomet tablets at 68°F to 77°F in a tightly closed container away from light and moisture, with brief excursions between 59°F and 86°F considered acceptable. Our pharmacist-supported team is available 24/7 by phone, chat, or email to help with questions about dosing schedules, storage, or choosing between our available strengths and package sizes. For a broader look at related treatment options, our diabetes medicines selection may also be useful.